Viewing Study NCT06823960


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2025-12-27 @ 11:33 PM
Study NCT ID: NCT06823960
Status: RECRUITING
Last Update Posted: 2025-02-12
First Post: 2025-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module